# Ram K. Shrivastava, M.D., New York, NY – FDA Inspections

Source: https://www.keypedia.com/companies/ram-k-shrivastava-md/528a41d2-1bcd-405b-a5fa-b2c85136c770

> Inspection records and compliance data for Ram K. Shrivastava, M.D. in New York, New York. 3 FDA inspections on record, 1 Form 483, last inspected July 26, 2019.

---

## Details

- Name: Ram K. Shrivastava, M.D.
- FEI Number: 3010969237
- Address Line 1: Eastside Comprehensive Medical Center, Llc, 4 E 89th St Apt 1a
- City: New York
- State: New York
- Zip Code: 10128
- Country Name: United States
- Address: Eastside Comprehensive Medical Center, Llc, 4 E 89th St Apt 1a, New York, New York 10128, United States
- Country: United States

## Related Documents

- [483 - Ram K. Shrivastava, M.D. - 2019-07-26](https://www.keypedia.com/records/483/ram-k-shrivastava-md/d84efc25-7089-4e6f-b5e2-57dd01d89fe4) — source: FDA, date: July 26, 2019
- [FDA Inspection 1097595 - Ram K. Shrivastava, M.D. - 2019-07-26](https://www.keypedia.com/records/fda_inspections/ram-k-shrivastava-md/5db2750f-a7bc-43a3-b897-eeafb8dc92e0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2019
- FDA Inspection 940867 - Ram K. Shrivastava, M.D. - 2015-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2015
- FDA Inspection 898262 - Ram K. Shrivastava, M.D. - 2014-09-18 — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2014

## Related Companies

- [McKesson Corporation dba RxPak](https://www.keypedia.com/companies/mckesson-corporation-dba-rxpak/d65f7265-a6b2-409b-958a-a69365e81ded)
- [Vanton Research Laboratory, LLC](https://www.keypedia.com/companies/vanton-research-laboratory-llc/a8b09eac-f6c5-4e79-88d6-df9f7e8d9240)
- [Exemplar Pharmaceuticals LLC](https://www.keypedia.com/companies/exemplar-pharmaceuticals-llc/151a6f00-549b-403b-b79f-3d979f6246b5)
- [Alvogen, Inc](https://www.keypedia.com/companies/alvogen-inc/685658a8-f147-4c48-8874-4c6dcbd66bb8)
- [NORTHEAST BIOLAB](https://www.keypedia.com/companies/northeast-biolab/df8bbc09-ec35-4998-88e5-8b66c2764e36)
- [Blueprint Medicines Corporation](https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa)
- [Bruce A. Segal, M.D.](https://www.keypedia.com/companies/bruce-a-segal-md/e5c9f73b-20f8-448f-b213-11ebe8c771b0)
- [Seatex LLC](https://www.keypedia.com/companies/seatex-llc/4dd6c435-911b-40f7-85f1-e55b0582ba5c)
- [Option Care Enterprises, Inc.](https://www.keypedia.com/companies/option-care-enterprises-inc/3ee774fb-3d80-4f2f-bf1b-efc0f3833e71)
- [Xeris Pharmaceuticals, Inc.](https://www.keypedia.com/companies/xeris-pharmaceuticals-inc/9cbcaba7-f788-4118-a53e-0134b660ffb5)

## Related Officers

- [investigator](https://www.keypedia.com/people/kelly-n-kerr/6f9e1ba0-61ca-403d-a337-9efece792c21)
